"Just Co-Incidence", Epi-Pen (Part Two)

Yesterday we learned that the CEO of Mylan/Epi-Pen is the daughter of US Senator Manchin (D).  Heather Bresch was well-paid for her position:  about $19,000,000.00 in 2015.

This was while Epi-Pen's price increased by near 500%.

In another *co-incidence*, the company scored a LARGE increase in revenues from the US Government just after The Daughter took over, from $0 in 2012 to $1.5 million in 2014.

And in a third *co-incidence* we find that the FDA has granted Ms. Bresch's company a monopoly on this treatment.  FDA is another of the sprawl of Gummint agencies, of course.

No doubt that all of this is perfectly legal.

So is the Clinton Foundation.